Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial.

Hitre, E; Budai, B; Takácsi-Nagy, Z; Rubovszky, G; Tóth, E; Remenár, É; Polgár, C; Láng, I

Hitre, E; Budai, B; Takácsi-Nagy, Z; Rubovszky, G; Tóth, E; Remenár, É; Polgár, C; Láng, I.

Affiliation

Hitre E; National Institute of Oncology, Ráth Gy. u. 7-9, 1122 Budapest, Hungary.

Br J Cancer ; 109(5): 1117-22, 2013 Sep 03.

Article in En | MEDLINE | ID: mdl-23942070

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Agents/therapeutic use; Carcinoma, Adenoid Cystic; Cisplatin/therapeutic use; Fluorouracil/therapeutic use; Adult; Aged; Antibodies, Monoclonal, Humanized/adverse effects; Antineoplastic Agents/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Adenoid Cystic/drug therapy; Carcinoma, Adenoid Cystic/mortality; Carcinoma, Adenoid Cystic/radiotherapy; Cetuximab; Combined Modality Therapy/adverse effects; Disease-Free Survival; ErbB Receptors/metabolism; Female; Humans; Male; Middle Aged; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Cisplatin / Carcinoma, Adenoid Cystic / Antibodies, Monoclonal, Humanized / Fluorouracil / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google